Literature DB >> 16537595

Selection of novel vesicular stomatitis virus glycoprotein variants from a peptide insertion library for enhanced purification of retroviral and lentiviral vectors.

Julie H Yu1, David V Schaffer.   

Abstract

The introduction of new features or functions that are not present in an original protein is a significant challenge in protein engineering. For example, modifications to vesicular stomatitis virus glycoprotein (VSV-G), which is commonly used to pseudotype retroviral and lentiviral vectors for gene delivery, have been hindered by a lack of structural knowledge of the protein. We have developed a transposon-based approach that randomly incorporates designed polypeptides throughout a protein to generate saturated insertion libraries and a subsequent high-throughput selection process in mammalian cells that enables the identification of optimal insertion sites for a novel designed functionality. This method was applied to VSV-G in order to construct a comprehensive library of mutants whose combined members have a His6 tag inserted at likely every site in the original protein sequence. Selecting the library via iterative retroviral infections of mammalian cells led to the identification of several VSV-G-His6 variants that were able to package high-titer viral vectors and could be purified by Ni-nitrilotriacetic acid affinity chromatography. Column purification of vectors reduced protein and DNA impurities more than 5,000-fold and 14,000-fold, respectively, from the viral supernatant. This substantially improved purity elicited a weaker immune response in the brain, without altering the infectivity or tropism from wild-type VSV-G-pseudotyped vectors. This work applies a powerful new tool for protein engineering to construct novel viral envelope variants that can greatly improve the safety and use of retroviral and lentiviral vectors for clinical gene therapy. Furthermore, this approach of library generation and selection can readily be extended to other challenges in protein engineering.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537595      PMCID: PMC1440395          DOI: 10.1128/JVI.80.7.3285-3292.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography.

Authors:  M Scherr; K Battmer; M Eder; S Schüle; H Hohenberg; A Ganser; M Grez; U Blömer
Journal:  Gene Ther       Date:  2002-12       Impact factor: 5.250

2.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells.

Authors:  Jolene M Ignowski; David V Schaffer
Journal:  Biotechnol Bioeng       Date:  2004-06-30       Impact factor: 4.530

4.  The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.

Authors:  L Lefrancois; D S Lyles
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

5.  Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or production.

Authors:  Huang-Ge Zhang; Jinfu Xie; Igor Dmitriev; Elena Kashentseva; David T Curiel; Hui-Chen Hsu; John D Mountz
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  A direct transposon insertion tool for modification and functional analysis of viral genomes.

Authors:  Heikki Vilen; Juha-Matti Aalto; Anna Kassinen; Lars Paulin; Harri Savilahti
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

Authors:  L Naldini; U Blömer; F H Gage; D Trono; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

8.  Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.

Authors:  B W Wu; J Lu; T K Gallaher; W F Anderson; P M Cannon
Journal:  Virology       Date:  2000-03-30       Impact factor: 3.616

9.  Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus.

Authors:  N Emi; T Friedmann; J K Yee
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy.

Authors:  Laura Tuschong; Sherry L Soenen; R Michael Blaese; Fabio Candotti; Linda Mesler Muul
Journal:  Hum Gene Ther       Date:  2002-09-01       Impact factor: 5.695

View more
  20 in total

1.  High-throughput, library-based selection of a murine leukemia virus variant to infect nondividing cells.

Authors:  Julie H Yu; David V Schaffer
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  A filamentous molecular chaperone of the prefoldin family from the deep-sea hyperthermophile Methanocaldococcus jannaschii.

Authors:  Timothy A Whitehead; Boonchai B Boonyaratanakornkit; Volker Höllrigl; Douglas S Clark
Journal:  Protein Sci       Date:  2007-04       Impact factor: 6.725

Review 3.  Molecular engineering of viral gene delivery vehicles.

Authors:  David V Schaffer; James T Koerber; Kwang-il Lim
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

4.  An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells.

Authors:  Jae-Hyung Jang; James T Koerber; Jung-Suk Kim; Prashanth Asuri; Tandis Vazin; Melissa Bartel; Albert Keung; Inchan Kwon; Kook In Park; David V Schaffer
Journal:  Mol Ther       Date:  2011-01-11       Impact factor: 11.454

5.  cAMP and EPAC Signaling Functionally Replace OCT4 During Induced Pluripotent Stem Cell Reprogramming.

Authors:  Ashley L Fritz; Maroof M Adil; Sunnie R Mao; David V Schaffer
Journal:  Mol Ther       Date:  2015-02-10       Impact factor: 11.454

6.  Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells.

Authors:  Prashanth Asuri; Melissa A Bartel; Tandis Vazin; Jae-Hyung Jang; Tiffany B Wong; David V Schaffer
Journal:  Mol Ther       Date:  2011-11-22       Impact factor: 11.454

7.  HIV evades RNA interference directed at TAR by an indirect compensatory mechanism.

Authors:  Joshua N Leonard; Priya S Shah; John C Burnett; David V Schaffer
Journal:  Cell Host Microbe       Date:  2008-11-13       Impact factor: 21.023

8.  Akt increases sox2 expression in adult hippocampal neural progenitor cells, but increased sox2 does not promote proliferation.

Authors:  Joseph Peltier; Anthony Conway; Albert J Keung; David V Schaffer
Journal:  Stem Cells Dev       Date:  2010-12-22       Impact factor: 3.272

9.  Novel GP64 envelope variants for improved delivery to human airway epithelial cells.

Authors:  P L Sinn; B-Y Hwang; N Li; J L S Ortiz; E Shirazi; K R Parekh; A L Cooney; D V Schaffer; P B McCray
Journal:  Gene Ther       Date:  2017-09-07       Impact factor: 5.250

10.  Characteristics of oncolytic vesicular stomatitis virus displaying tumor-targeting ligands.

Authors:  Arun Ammayappan; Kah-Whye Peng; Stephen J Russell
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.